Responses
Clinical and epidemiological research
Extended report
A phase III randomised, double-blind, parallel-group study comparing SB4 with etanercept reference product in patients with active rheumatoid arthritis despite methotrexate therapy
Compose a Response to This Article
Other responses
No responses have been published for this article.